Evidence map›Paper›PMID 23850636›Full record

ArticleBiochimica et biophysica acta2013

Probing the interaction of Arg9Cys mutated phospholamban with phospholipid bilayers by solid-state NMR spectroscopy.

Xueting Yu, Gary A Lorigan

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Xueting YuDepartment of Chemistry and Biochemistry, Miami University, Oxford, OH 45056, USA.
Gary A Lorigan
Miami University · US

Funding

EPR and Solid-State NMR Studies of Integral Membrane ProteinsR01GM080542 · NIGMS · MIAMI UNIVERSITY OXFORD · PI LORIGAN, GARY A · 2007 to 2011
$1.6M
EPR Structural Studies of KCNE1/KCNQ1R01GM108026 · NIGMS · MIAMI UNIVERSITY OXFORD · PI LORIGAN, GARY A · 2013 to 2016
$1.3M
NIGMS NIH HHS GM080542ZNIGMS NIH HHS R01 GM080542NIGMS NIH HHS R01GM080542NIGMS NIH HHS R01 GM108026
6 · The paper itself

Abstract

Phospholamban (PLB) is a 52 amino acid integral membrane protein that interacts with the sarcoplasmic reticulum Ca(2+) ATPase (SERCA) and helps to regulate Ca(2+) flow. PLB inhibits SERCA impairing Ca(2+) translocation. The inhibition can be relieved upon phosphorylation of PLB. The Arg9 to Cys (R9C) mutation is a loss of function mutation with reduced inhibitory potency. The effect R9C PLB has on the membrane surface and the hydrophobic region dynamics was investigated by (31)P and (2)H solid-state NMR spectroscopy in multilamellar vesicles (MLVs). The (31)P NMR spectra indicate that, like the phosphorylated PLB (P-PLB), the mutated R9C-PLB protein has significantly less interaction with the lipid bilayer headgroup when compared to wild-type PLB (WT-PLB). Similar to P-PLB, R9C-PLB slightly decreases (31)P T1 values in the lipid headgroup region. (2)H SCD order parameters of (2)H nuclei along the lipid acyl chain decrease less dramatically for R9C-PLB and P-PLB when compared to WT-PLB. The results suggest that R9C-PLB interacts less with the membrane surface and hydrophobic region than WT-PLB. Detachment of the cytoplasmic domain of R9C-PLB from the membrane surface could be related to its loss of function.

Indexed as

Lipid BilayersArginineCalcium-Binding ProteinsCysteineMolecular ProbesNuclear Magnetic Resonance, BiomolecularPhospholambanPhospholipidsArginineCalcium-Binding ProteinsCysteineLipid BilayersMolecular ProbesPhospholambanPhospholipidsMembrane interactionMultilamellar vesiclePhospholambanSolid-state NMR spectroscopy

Identifiers

PMID23850636
PMCPMC3799966
OpenAlexW2074717066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.